Bringing the brightest minds together


The United Arab Emirates and the National Institutes of Health in the United States Collaborative Research Initiative (UAE-NIH-CRI)

UAE-NIH Collaborative Awards 2023

The Al Jalila Foundation, together with The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) and three United Arab Emirates (UAE) universities created the UAE-NIH Collaborative Research Initiative (UAE-NIH-CRI). The three partnering Universities are Mohammed Bin Rashid University of Medicine and Health Sciences, Khalifa University, and UAE University.

The UAE-NIH-CRI will support ongoing and new meritorious UAE-U.S. research cooperation.  It will foster cooperative research among UAE and U.S. investigators with shared priorities related to infectious, immunologic, and allergic diseases. It will also support building UAE capacity in biomedical research through scientific training opportunities. It is anticipated that the UAE-NIH-CRI will fund up to six meritorious awards over 3-years to support pioneering research collaborations among UAE and U.S. scientists, bringing the brightest minds together.


A council comprising of members representing the five partnering organisations will oversee the UAE-NIH-CRI, review the scientific merit of applications, make funding recommendations, and review progress reports. The merit review process will be handled independently by a panel of unconflicted experts.


Each partner organization will provide funding of $250,000 per year for up to three years with a total collective investment of $3,750,000 for the 3-year program.


The Request for Proposals (RFP) for the researchers to apply for the UAE-NIH-CRI awards was released on 31 August 2022 by CRDF Global, a non-governmental program implementation organization, and the application deadline is 16 December 2022. Grant recipients will be announced in the spring or early summer of 2023.


Eligible Applicant(s) Joint teams of UAE and U.S. investigators
Competition Opens Wednesday, August 31 (12:00 PM) Eastern Time (ET)

Wednesday, August 31 (8:00 PM) UAE Gulf Standard Time (GST)

Abstract Submission Deadline Friday, December 2, 2022 (3:59 PM) U.S. Eastern Time (ET)

Friday, December 2, 2022 (11:59 PM) UAE Gulf Standard Time (GST)

Proposal Submission Deadline Friday, December 16, 2022 (3:59 PM) U.S. Eastern Time (ET)

Friday, December 16, 2022 (11:59 PM) UAE Gulf Standard Time (GST)

Announcement of Results Monday, April 3, 2023 (9:00 AM) U.S. Eastern Time (ET)

Monday, April 3, 2023 (5:00 PM) UAE Gulf Standard Time (GST)

Eligible Research Scope Infectious Diseases, Allergy, and Immunology
Project Duration Up to three years
Award Amounts Each up to $175,000 total cost per year for up to three years of support
How to Apply Proposals must be submitted through CRDF Global.
Condition for Application


Each research team should have a minimum of three Principal Investigators (PIs). Two PIs must be from two different UAE research institutions, and one PI must be from the United States.

For the further information about this opportunity, and for the Application Package and process (including eligibility criteria, RFP, application form and FAQs), please visit CRDF Global website

For any questions pertaining to applying for this opportunity, please contact CRDF Global program staff: Ariyand Aminpour at and Kesina Kum at